|
Code
|
0863C
|
|
MA number
|
16/0398/16-S
|
|
Product Form:
|
plv ifo 1x1,5 mg (liek.inj.skl.)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
Janssen - Cilag International N.V., Belgium
|
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
|
ATC:
|
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B01 |
ANTITHROMBOTIC AGENTS |
| B01A |
ANTITHROMBOTIC AGENTS |
| B01AC |
Platelet aggregation inhibitors excl. heparin |
| B01AC09 |
Epoprostenol |
|
|
Shelf life:
|
36 |
|
Container:
|
glass vial
|
|
Route of admin.:
|
Intravenous use
|
SPC_VELETRI_0,5mg_1,5mg_11.2022.pdf
